• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含血小板血浆作为一种针对糖尿病足感染中多重耐药菌的潜在抗菌剂。

Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections.

作者信息

Aboelsaad Engy, Moustafa Sameh, Amine Amira, Deghady Akram, El-Attar Laila

机构信息

Department of Microbiology, High Institute of Public Health, Alexandria University, El-Horreya Road 165, Alexandria, 21561, Egypt.

Department of Vascular Surgery, Faculty of Medicine, Alexandria University, Chamblion Street, Alexandria, 21521, Egypt.

出版信息

Sci Rep. 2025 Apr 30;15(1):15145. doi: 10.1038/s41598-025-97418-0.

DOI:10.1038/s41598-025-97418-0
PMID:40307308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12043966/
Abstract

Diabetes mellitus is a global public health concern, with diabetic foot infections (DFIs) being common clinical complications among affected patients. Bacterial isolates resistant to commonly used antimicrobial drugs are becoming more prevalent in DFIs. Some research suggests that platelet-rich plasma (PRP) may inhibit bacterial growth, making it a promising biological therapy. Therefore, an in vitro experimental study was conducted on 53 multidrug-resistant (MDR) bacterial strains isolated from DFIs. The isolates were methicillin-resistant Staphylococcus aureus (MRSA), MDR Klebsiella pneumoniae, and MDR Pseudomonas aeruginosa. The antibacterial activity of PRP was assessed using Kirby-Bauer disk diffusion method, broth microdilution method, checkerboard synergy testing, and time-kill assay. The time-kill assay demonstrated that PRP's antibacterial efficacy peaked during the second hour of incubation for MRSA and Pseudomonas aeruginosa, but peaked at the first hour for Klebsiella pneumoniae. However, the PPR's efficiency against all isolates decreased after the peak point, with no antibacterial activity observed at the 24th h of incubation. Additionally, biofilm inhibition and eradication assays revealed that PRP has no effect on biofilm formation. As a result, PRP has the ability to inhibit bacterial growth, although this effect is transient and depends on the bacterial strain.

摘要

糖尿病是一个全球性的公共卫生问题,糖尿病足感染(DFIs)是糖尿病患者常见的临床并发症。对常用抗菌药物耐药的细菌分离株在糖尿病足感染中越来越普遍。一些研究表明,富血小板血浆(PRP)可能会抑制细菌生长,使其成为一种有前景的生物疗法。因此,对从糖尿病足感染中分离出的53株多重耐药(MDR)细菌菌株进行了一项体外实验研究。这些分离株包括耐甲氧西林金黄色葡萄球菌(MRSA)、多重耐药肺炎克雷伯菌和多重耐药铜绿假单胞菌。采用 Kirby-Bauer 纸片扩散法、肉汤微量稀释法、棋盘协同试验和时间杀菌试验评估了PRP的抗菌活性。时间杀菌试验表明,PRP对MRSA和铜绿假单胞菌的抗菌效果在孵育的第2小时达到峰值,但对肺炎克雷伯菌在第1小时达到峰值。然而,PRP对所有分离株的抗菌效率在峰值点之后下降,在孵育24小时时未观察到抗菌活性。此外,生物膜抑制和清除试验表明,PRP对生物膜形成没有影响。因此,PRP具有抑制细菌生长的能力,尽管这种作用是短暂的,并且取决于细菌菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1384ba795acd/41598_2025_97418_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1571040c4583/41598_2025_97418_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/810d7844c67b/41598_2025_97418_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/6d683af06f17/41598_2025_97418_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/092f6148239f/41598_2025_97418_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/c20af786a5be/41598_2025_97418_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/6520eaeb543b/41598_2025_97418_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/e7a264e6b593/41598_2025_97418_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/7e4e4292f311/41598_2025_97418_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/0b684f4af576/41598_2025_97418_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/a9c93cf7c667/41598_2025_97418_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/45b1eb103813/41598_2025_97418_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/23f4c7ff48fd/41598_2025_97418_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1d568a9afe57/41598_2025_97418_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/bacddd6e1f8f/41598_2025_97418_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/109a76ba10bd/41598_2025_97418_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/92de53121c68/41598_2025_97418_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/72ee3b310661/41598_2025_97418_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1384ba795acd/41598_2025_97418_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1571040c4583/41598_2025_97418_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/810d7844c67b/41598_2025_97418_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/6d683af06f17/41598_2025_97418_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/092f6148239f/41598_2025_97418_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/c20af786a5be/41598_2025_97418_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/6520eaeb543b/41598_2025_97418_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/e7a264e6b593/41598_2025_97418_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/7e4e4292f311/41598_2025_97418_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/0b684f4af576/41598_2025_97418_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/a9c93cf7c667/41598_2025_97418_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/45b1eb103813/41598_2025_97418_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/23f4c7ff48fd/41598_2025_97418_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1d568a9afe57/41598_2025_97418_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/bacddd6e1f8f/41598_2025_97418_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/109a76ba10bd/41598_2025_97418_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/92de53121c68/41598_2025_97418_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/72ee3b310661/41598_2025_97418_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b4/12043966/1384ba795acd/41598_2025_97418_Fig18_HTML.jpg

相似文献

1
Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections.富含血小板血浆作为一种针对糖尿病足感染中多重耐药菌的潜在抗菌剂。
Sci Rep. 2025 Apr 30;15(1):15145. doi: 10.1038/s41598-025-97418-0.
2
Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study.富血小板血浆作为治疗多重耐药菌感染创面的一种附加治疗选择:体外抗菌活性研究。
Eur J Trauma Emerg Surg. 2019 Jun;45(3):555-565. doi: 10.1007/s00068-018-0957-0. Epub 2018 Apr 26.
3
Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.糖尿病足感染中金黄色葡萄球菌生物膜的药敏模式
BMC Microbiol. 2016 Jun 23;16(1):119. doi: 10.1186/s12866-016-0737-0.
4
Evaluation of chlorogenic acid and carnosol for anti-efflux pump and anti-biofilm activities against extensively drug-resistant strains of and .评价绿原酸和卡诺醇对广泛耐药株 和 的抗外排泵和抗生物膜活性。
Microbiol Spectr. 2024 Sep 3;12(9):e0393423. doi: 10.1128/spectrum.03934-23. Epub 2024 Jul 24.
5
Molecular characterization of from diabetic foot infections in Tunisia.从突尼斯糖尿病足感染中分离的的分子特征。
J Med Microbiol. 2024 Jul;73(7). doi: 10.1099/jmm.0.001851.
6
High Efficacy of Ozonated Oils on the Removal of Biofilms Produced by Methicillin-Resistant (MRSA) from Infected Diabetic Foot Ulcers.臭氧油去除感染性糖尿病足溃疡中产甲氧西林耐药金黄色葡萄球菌(MRSA)生物膜的高效性。
Molecules. 2020 Aug 7;25(16):3601. doi: 10.3390/molecules25163601.
7
Disrupting antimicrobial resistance: unveiling the potential of vitamin C in combating biofilm formation in drug-resistant bacteria.破坏抗微生物耐药性:揭示维生素C在对抗耐药菌生物膜形成方面的潜力。
BMC Microbiol. 2025 Apr 12;25(1):212. doi: 10.1186/s12866-025-03800-3.
8
Ultrastructural polymicrobial interactions and antimicrobial resistance in cornea model.角膜模型中的超微结构多微生物相互作用及抗菌耐药性
Future Microbiol. 2025 Feb;20(2):117-135. doi: 10.1080/17460913.2024.2417617. Epub 2024 Nov 6.
9
Whole genome sequencing based prediction of antimicrobial resistance evolution among the predominant bacterial pathogens of diabetic foot ulcer.基于全基因组测序对糖尿病足溃疡主要病原菌耐药性演变的预测
World J Microbiol Biotechnol. 2025 May 2;41(5):161. doi: 10.1007/s11274-025-04362-2.
10
In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.生物活性玻璃 S53P4 对引起骨髓炎和人工关节感染的多药耐药病原体的体外抗菌活性。
BMC Infect Dis. 2018 Apr 3;18(1):157. doi: 10.1186/s12879-018-3069-x.

本文引用的文献

1
Erratum to "IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045" [Diabetes Res. Clin. Pract. 183 (2022) 109119].《国际糖尿病联盟糖尿病地图集:2021年全球、区域和国家层面糖尿病患病率估计及2045年预测》勘误 [糖尿病研究与临床实践183 (2022) 109119] 。
Diabetes Res Clin Pract. 2023 Oct;204:110945. doi: 10.1016/j.diabres.2023.110945. Epub 2023 Oct 19.
2
Pseudomonas aeruginosa's greenish-blue pigment pyocyanin: its production and biological activities.铜绿假单胞菌的蓝绿色色素绿脓菌素:其生产与生物活性。
Microb Cell Fact. 2023 Jun 8;22(1):110. doi: 10.1186/s12934-023-02122-1.
3
Antibacterial Properties of Canine Platelet-Rich Plasma and Other Non-Transfusional Hemo-Components: An Study.
犬富血小板血浆及其他非输血性血液成分的抗菌特性:一项研究
Front Vet Sci. 2021 Oct 4;8:746809. doi: 10.3389/fvets.2021.746809. eCollection 2021.
4
The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review.多重耐药菌对糖尿病足溃疡临床结局的影响:一项系统综述
J Clin Med. 2021 May 1;10(9):1948. doi: 10.3390/jcm10091948.
5
Microtiter plate assays to assess antibiofilm activity against bacteria.微孔板法检测抗细菌生物膜活性。
Nat Protoc. 2021 May;16(5):2615-2632. doi: 10.1038/s41596-021-00515-3. Epub 2021 Apr 28.
6
An evaluation of the bacteriostatic effect of platelet-rich plasma.富血小板血浆的抑菌效果评价。
Int Wound J. 2021 Aug;18(4):448-456. doi: 10.1111/iwj.13545. Epub 2021 Jan 21.
7
Technical Procedures for Preparation and Administration of Platelet-Rich Plasma and Related Products: A Scoping Review.富血小板血浆及相关产品制备与给药的技术程序:一项范围综述
Front Cell Dev Biol. 2020 Dec 11;8:598816. doi: 10.3389/fcell.2020.598816. eCollection 2020.
8
Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data.估算糖尿病导致的寿命损失年数:基于国家糖尿病审计与国家统计局数据分析的结果
Cardiovasc Endocrinol Metab. 2020 Jun 2;9(4):183-185. doi: 10.1097/XCE.0000000000000210. eCollection 2020 Dec.
9
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update).糖尿病足感染的诊断和治疗指南(IWGDF 2019 更新)。
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280. doi: 10.1002/dmrr.3280.
10
Risk of diabetic foot ulcer and its associated factors among Bangladeshi subjects: a multicentric cross-sectional study.孟加拉国人群中糖尿病足溃疡的风险及其相关因素:一项多中心横断面研究。
BMJ Open. 2020 Feb 28;10(2):e034058. doi: 10.1136/bmjopen-2019-034058.